Assessment of Relative Bioavailability of Moroctocog Alfa and Moroctocog Alfa (AF‐CC) in Subjects With Severe Hemophilia A

por Korth‐Bradley, Joan, Rupon, Jeremy, Plotka, Anna, Charnigo, Robert, Rendo, Pablo
Publicado 2018

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa

por Rendo, Pablo, Lamb, Janice, Smith, Lynne, Fuiman, Joanne, Korth-Bradley, Joan M.
Publicado 2018

First open-label, single-arm, prospective study of real-world use of FIX replacement therapy in a predominantly pediatric hemophilia B population in China

por Yang, Renchi, Wu, Runhui, Sun, Jing, Sun, Feifei, Rupon, Jeremy, Huard, Francois, Korth-Bradley, Joan M., Xu, Lihong, Luo, Binyu, Liu, Yingxue Cathy, Rendo, Pablo
Publicado 2021

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies

por Yang, Renchi, Zhao, Yongqiang, Wang, Xuefeng, Sun, Jing, Wu, Runhui, Jin, Chenghao, Jin, Jie, Wu, Depei, Rendo, Pablo, Sun, Feifei, Rupon, Jeremy, Huard, Francois, Korth-Bradley, Joan M, Xu, Lihong, Luo, Binyu, Liu, Yingxue Cathy
Publicado 2020